Login
Registration enables users to use special features of this website, such as past
order histories, retained contact details for faster checkout, review submissions, and special promotions.
order histories, retained contact details for faster checkout, review submissions, and special promotions.
Forgot password?
Registration enables users to use special features of this website, such as past
order histories, retained contact details for faster checkout, review submissions, and special promotions.
order histories, retained contact details for faster checkout, review submissions, and special promotions.
Quick Order
Products
Antibodies
ELISA and Assay Kits
Research Areas
Infectious Disease
Resources
Purchasing
Reference Material
Contact Us
Location
Corporate Headquarters
Vector Laboratories, Inc.
6737 Mowry Ave
Newark, CA 94560
United States
Telephone Numbers
Customer Service: (800) 227-6666 / (650) 697-3600
Contact Us
Additional Contact Details
Login
Registration enables users to use special features of this website, such as past
order histories, retained contact details for faster checkout, review submissions, and special promotions.
order histories, retained contact details for faster checkout, review submissions, and special promotions.
Forgot password?
Registration enables users to use special features of this website, such as past
order histories, retained contact details for faster checkout, review submissions, and special promotions.
order histories, retained contact details for faster checkout, review submissions, and special promotions.
Quick Order
| Catalog Number | Size | Price |
|---|---|---|
| LS-G138913-10 | 10 µg | $262 |
| LS-G138913-50 | 50 µg | $361 |
Human SIRPA / CD172a Protein (Recombinant His,C-terminus) (Glu31-Arg370) - LS-G138913
Human SIRPA / CD172a Protein (Recombinant His,C-terminus) (Glu31-Arg370) - LS-G138913
Description:
SIRPA / CD172a Protein LS-G138913 is a Recombinant Human SIRPA / CD172a produced in Mammalian Cells Glu31-Arg370 with His,C-terminus tag(s). It is low in endotoxin; Less than 1.0 EU/µg protein (determined by LAL method). For Research Use Only
Toll Free North America
(800) 227-6666
(800) 227-6666For Research Use Only
Overview
Description:
SIRPA / CD172a Protein LS-G138913 is a Recombinant Human SIRPA / CD172a produced in Mammalian Cells Glu31-Arg370 with His,C-terminus tag(s). It is low in endotoxin; Less than 1.0 EU/µg protein (determined by LAL method). For Research Use Only
Specifications
Type
Recombinant Protein
Target
SIRPA / CD172a
Synonyms
SIRPA | CD172A | CD172a antigen | Inhibitory receptors shps-1 | Inhibitory receptor SHPS-1 | Macrophage fusion receptor | MyD-1 antigen | p84 | SHPS-1 | SHPS1 | SIRP | Sirp-alpha-1 | Sirp-alpha-3 | Sirp-alpha1 | MYD1 | SIRPalpha | SIRPalpha2 | BIT | MFR | MYD-1 | PTPNS1 | SHP substrate 1 | Sirp-alpha-2 | CD172
Species
Human
Modifications
Unmodified
Conjugations
Unconjugated
Tag
His,C-terminus
Region
Glu31-Arg370
Predicted Molecular Weight
38.31 kDa
Expression System
Mammalian Cells
Source Species
Mammal
Purification
Greater than 95% by SDS-PAGE
Usage Summary
Recombinant Human CD172a is produced by our Mammalian expression system and the target gene encoding Glu31-Arg370 is expressed with a 6His tag at the C-terminus.
Bio-Activity
Not Tested
Endotoxin
Less than 1.0 EU/µg protein (determined by LAL method).
Presentation
Lyophilized from a sterile solution in 20 mM PB, pH 7.2, 150 mM NaCl
Storage
Store lyophilized at room temperature for up to 3 weeks, or at -20°C or below. Aliquot and store reconstituted at 4°C-7°C for up to 1 week, or at -20°C or below for up to 3 months. Avoid freeze/thaw cycles.
Restrictions
For research use only. Intended for use by laboratory professionals.
About SIRPA / CD172a
Publications (0)
Customer Reviews (0)
Popular SIRPA / CD172a Proteins
Source:
E. coli
Tag:
His, N-Terminal
Source:
Human
Tag:
Fc, C-terminus
Request SDS/MSDS
To request an SDS/MSDS form for this product, please contact our Technical Support department at:
Technical.Support@LSBio.com
Requested From: United States
Date Requested: 11/28/2024
Date Requested: 11/28/2024
